PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 253 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BALYASNY ASSET MANAGEMENT L.P. | 644,738 | $25,834,652 | 0.06% |
| Magnetar Financial LLC | 65,370 | $2,619,376 | 0.06% |
| Candriam S.C.A. | 191,901 | $7,689,473 | 0.06% |
| Baillie Gifford | 1,658,563 | $66,458,619 | 0.06% |
| Woodline Partners LP | 108,376 | $4,342,626 | 0.05% |
| ROYCE & ASSOCIATES LP | 124,382 | $4,983,987 | 0.05% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 838,935 | $33,616,125 | 0.05% |
| abrdn plc | 476,421 | $19,090,190 | 0.04% |
| Headlands Technologies LLC | 3,255 | $130,428 | 0.04% |
| ClearBridge Investments | 1,154,149 | $46,246,735 | 0.04% |
| FEDERATED HERMES, INC. | 408,058 | $16,350,884 | 0.04% |
| SEGALL BRYANT & HAMILL, LLC | 94,444 | $3,784,372 | 0.04% |
| READYSTATE ASSET MANAGEMENT LP | 13,200 | $528,924 | 0.04% |
| Inspire Investing, LLC | 7,847 | $314,429 | 0.04% |
| MOORE CAPITAL MANAGEMENT, LP | 55,000 | $2,203,850 | 0.04% |
| Polaris Capital Management, LLC | 25,300 | $1,013,771 | 0.04% |
| Schonfeld Strategic Advisors LLC | 102,823 | $4,120,117 | 0.04% |
| SILVERCREST ASSET MANAGEMENT GROUP LLC | 122,854 | $4,922,760 | 0.04% |
| Quantbot Technologies LP | 12,701 | $508,929 | 0.03% |
| MACQUARIE GROUP LTD | 726,658 | $29,117,000 | 0.03% |
External links
This page lists PACIRA PHARMACEUTICALS INC's shareholders in Q2 2023. To view PACIRA PHARMACEUTICALS INC's shareholder history, click here.